In partnership with
AIHealthTech Insider: Issue #125
November 2, 20263w2q`
Illustrations in this issue are AI-generated.
Hello,
An AI answer can sound convincing. A medication dose still needs checking.
This week: a tool designed to verify AI-generated doses, cancer predictions from pathology slides and a vaccine result that needs more context than “99%.”
For education, not medical advice.
☕ Quick question before we dive in 👇
Researchers asked 9 AI models 8,000+ dosing questions. How many dose claims do you think were wrong?
👇 Later in this issue: A pancreatic cancer vaccine triggered an immune response—but did it prevent recurrence?
🔬 The Big Story
Who checks the dose when AI suggests a medicine?
Doximity has introduced DoseCheck, a tool designed to check AI-generated medication doses against a structured drug database.
Image source: Doximity
In the company’s evaluation of nine AI models, at least 2.3% of dosage claims were incorrect. The research covered more than 8,000 dosing questions.
DoseCheck uses database checks and links to FDA prescribing information, giving clinicians a way to inspect the supporting source.
Why it matters: A fluent answer doesn’t establish that the dose fits the drug, patient or situation.
The honest part: This was a company-reported evaluation accompanying a product launch. Checking a dose against a database doesn’t replace reviewing kidney function, interactions and other patient-specific factors.
New here? Join 1,500+ readers getting one carefully sourced AI-healthcare briefing every Monday—written in plain English, without the hype.
🤎 Sponsored
Glass Skin Goals? Meet Your Morning Upgrade
Glass skin is the fall beauty goal: a complexion that looks smooth, plump and luminous. Pique’s Carrara Marine Collagen makes supporting that glow a delicious part of your morning routine.
After 90 days on Carrara, 83% reported smoother skin, 80% reported plumper skin and 86% reported greater skin satisfaction.
Each serving combines Type I marine collagen to support skin radiance with rare Type II collagen, sourced from wild Hokkaido salmon, to support elasticity. Together, they bring skin support into a daily ritual that feels like a treat.
Two scoops blend into morning matcha for a creamy latte, making consistency easy as fall schedules fill up. A warm cup, a quiet moment and nourishment from within become part of the same routine.
For anyone pursuing that luminous glass-skin look through sweater season, Carrara adds a beauty upgrade to a habit they already love.
⚡ Quick Hits
🔸Can AI help predict how a cancer will behave?
Valar Labs is developing AI that reads routine pathology slides to identify patterns linked to cancer risk and treatment response.
Its late-October update explains how measurements of cells and surrounding tissue could help inform clinical decisions.
The honest part: This is the company’s account of its technology. It doesn’t establish that AI consistently chooses better treatments or improves patient survival.
🔸AI agents could help book your next appointment
Zocdoc is opening its platform to registered AI agents, allowing them to search participating providers, check availability and book appointments with patients’ consent.
The company says agents can use information about location, specialty and accepted insurance when finding appointments.
The honest part: Accepting an insurance plan doesn’t guarantee that a particular visit is covered. Patients should still confirm benefits and expected costs.
Know someone in healthcare, medicine, or AI? Forward this to them. They can subscribe free here →
🧠 Brain in Brief
What could your voice reveal about aging?
An NIH research briefing highlights a study of 2,928 Spanish-speaking adults across five Latin American countries.
Researchers analyzed features such as speech timing, pitch and word use. Their speech-based measures were associated with aging and cognitive health.
Why it matters: Speech could offer an accessible way to study changes that are difficult to track outside a clinic.
The honest part: This isn’t a diagnostic voice test. Researchers need further validation across languages, populations and longer follow-up periods.
🤎 Sponsored
Make connection part of your routine.
Take ZOLEO on your next hike for messaging and “I’m OK” check-in messages beyond cell coverage. Save 20% on a regularly priced ZOLEO Satellite Communicator with code STAYCONNECTED20.
Not valid on sale-priced devices or with other discounts. Valid outside promotional sale periods.
🌿 Worth Knowing
A pancreatic cancer vaccine triggered an immune response. Did it stop recurrence?
An experimental vaccine called camupepimut produced increased cancer-targeting T-cell responses in 89 of 90 (about 99%) vaccinated patients whose responses could be measured.
The randomized phase 2 trial involved 144 patients following surgery and standard treatment. Researchers also observed that stronger immune responses were associated with longer disease-free survival among vaccinated participants.
The honest part: The trial did not show a statistically significant improvement in disease-free survival overall. An immune response isn’t proof that the vaccine prevents recurrence or extends life. Larger studies are needed.
One useful question this week
When a healthcare technology makes a promising claim, ask:
“What did researchers actually measure—and did patients benefit?”
A correct database match, a cancer prediction and an immune response each tell us something useful. They answer different questions.
Know someone who enjoys health research without the jargon? Forward this issue.
